FDA Commissioner Scott Gottlieb, MD, delivered the opening remarks at the American Society of Clinical Oncology’s 2018 annual meeting at McCormick Place in Chicago, emphasizing his organization’s goal of reducing the time needed to connect cancer patients with treatment.